Top Tweets for #KLTO
$KLTO
#KLTO
للتعليم والفائده بـ #مؤشر_أبو_لجين_العطاوي وقفك 0.2900
#مؤشر_أبو_لجين_العطاوي
#السوق_الامريكي
#السوق_الامريكي_بالعربي
#XAUUSD
#الذهب
#Stocks #Crypto #GOLD #SILVER #BTCUSDT #Bitcoin #Forex #BTC
#السوق_السعودي_تداول #تداول #الاسهم_السعودية #spx500
#Trading
#Forex
#Investing
#Bitcoin
#Stocks
#SMC
#ITC
#Crypto
#AUXUSD
#NDX
#SPX
#تداول_العملات
#تداول
#تداول_العملات_الرقمية
#الفوركس
#الاسهم_السعودية
#الاسهم_الامريكية
#البتكوين
#تاسي
#تاسي_الفخم
Dr. Joseph Sinkule, Founder & CEO of $KLTO, joined @Xtalks to discuss how the #Klotho gene is shaping next-gen #ALS and #Alzheimers research.
From biomarkers to AAV delivery and scalable manufacturing, the science behind #KLTO continues to advance.
Read more: https://t.co/oAm17mokhH
The 7th issue of Xtalks Clinical Edge is here! A special thanks to our front-cover interviewee, Martin Beck, Boehringer Ingelheim, for sharing insights on improving awareness and patient-centered research in idiopathic pulmonary fibrosis. See more for 12 in-depth conversations with leaders advancing clinical research across therapeutic areas:
🧬 Immunology & Inflammatory Disease
Paul F. Lizzul, MD, PhD, MPH, MBA, AnaptysBio
Niels Riedemann, MD, PhD, InflaRx
👩🔬 Respiratory Research
Martin Beck, Boehringer Ingelheim
Barry Quart, PharmD, Connect Biopharma
🧠 Neurology, Ophthalmology & Ischemic Disease
Ahmed Enayetallah, MD, PhD, Dompé
Joseph Sinkule, @KlothoNeuroSci
Rick Pauls, @DiaMedica
🎯 Oncology & Women’s Health
Steven Quay, MD, PhD, @Atossainc
📊 Data, Evidence & Global Access
Awny Farajallah, MD, FACP, Takeda
Gerry Muhle, @Galderma
🩺 Medtech & Diagnostics
Linnea Burman, @Medtronic_NV
Neil Klompas, @Augurex
Each conversation highlights how evolving biology, smarter trial design and real-world evidence are helping translate discovery into meaningful patient impact.
Read Xtalks Clinical Edge, Issue 7: https://t.co/T01S5ns1Dd
#XtalksClinicalEdge #ClinicalResearch #ClinicalTrials #Pharma #Biotech #Medtech #LifeSciences
In a new Drug Development & Delivery feature, $KLTO CEO, Joseph Sinkule, shares how the Company is advancing a #genetherapy approach to address #neurodegenerative and age-related disorders.
Read more: https://t.co/GyMMLeL6zP
#KLTO #ALS
In a new Drug Development & Delivery feature, $KLTO CEO, Joseph Sinkule, shares how the Company is advancing a #genetherapy approach to address #neurodegenerative and age-related disorders.
Read more: https://t.co/GyMMLeLEpn
#KLTO #ALS
As the new year begins, $KLTO is back and focused on advancing our gene therapy platform built on the secreted form of the human α-Klotho gene.
In 2026, #KLTO remains committed to progress in #neurodegenerative and age-related diseases.
Learn more: https://t.co/PFX7FwS6zN
Happy Holidays from all of us at #KlothoNeurosciences!
Wishing everyone a season filled with health, peace, and new possibilities as we look ahead to the year to come.
#KLTO #HolidaySeason
#KLTO's CEO, Dr. Joseph Sinkule, shares how #KlothoNeurosciences is advancing a Klotho-based gene therapy for #ALS in a new @LongevityTech feature.
Read more about KLTO-202 and its role in #neurodegeneration: https://t.co/21rChPSfZ2
#KlothoNeurosciences is honored to receive the @BioTech_Awards' Cell Therapy Innovation of the Year Award!
This award recognizes #KLTO's work advancing cell and #genetherapy for neurodegenerative disorders.
Full release: https://t.co/ahiHSXYYkt
#BiotechAwards $KLTO
Today, we're proud to highlight the #KlothoNeurosciences' Board of Directors, Dr. Joseph Sinkule, Shalom Hirshman, Riad El-Dada, Dr. Samuel Zentman, and Jon McGarity.
Each of their expertise drives #KLTO’s progress in #genetherapy.
Learn more: https://t.co/efLtmlOoGS
$KLTO
#KLTO is pioneering biologic medicines. $KLTO's #genetherapy delivers α-Klotho into human cells, letting the body produce it naturally. Named after the Greek goddess of life, α-Klotho shows promise for memory loss, neuromuscular & kidney health.
Learn more: https://t.co/v5sn4qXtdV
#KlothoTherapeutics' CEO, Dr. Joseph Sinkule, believes in innovation & collaboration.
In @pharmasalmanac, he shares how #KLTO is tackling #cellandgenetherapy challenges & advancing #neurodegenerativedisease with novel delivery systems.
Learn more: https://t.co/PFX7FwS6zN
$KLTO
Meet #KlothoNeurosciences' CFO, Jeffrey LeBlanc. With 20+ years in finance, investing, and venture creation, he helps guide our growth and strategic vision.
Learn more about our leadership team: https://t.co/EZzGQWWqdX
$KLTO #KLTO #KlothoNeuro
#KlothoNeurosciences' Founder and CEO, Dr. Sinkule, brings over 46 years of experience and leadership within the #pharmaceutical and #biotechnology industries.
Learn more: https://t.co/67JIV60aOj
$KLTO #KLTO #KlothoNeuro
#KlothoNeurosciences announces CEO & Chairman, Dr. Joseph Sinkule, will attend the Inaugural #Klotho Conference & Scientific Seminar at @UCICove. This is first conference on the future of klotho-based therapies & diagnostics.
Read more: https://t.co/L9EAtMaWJ1
#KLTO $KLTO
Sharing a story from @pharmasalmanac on roadblocks in bringing #cellandgenetherapy to patients.
#KlothoTherapeutics' CEO, Dr. Joseph Sinkule, highlights manufacturing challenges and how #KLTO and @aavnergene are advancing AAV vectors for #neurodegenerativedisease.
Full article: https://t.co/CmPc6eJ1QL
$KLTO
#ALS is a progressive disease that damages motor neurons and impacts thousands each year.
At $KLTO, we are advancing gene and cell therapies to slow progression and improve outcomes for ALS and other #neurodegenerativediseases.
Learn more: https://t.co/PFX7FwRyKf
#KLTO
$KLTO is focused on the development of innovative, disease-modifying cell and #genetherapies using a protein derived from an exclusively licensed and patented form of the "anti-aging" human Klotho gene (s-KL) known as a-Klotho.
Learn more here: https://t.co/0nVpdwGHvq
#KLTO
#KLTO
اتجاه عرضي علي المدي القصير اعلي مستوي الدعم الحالي 0.76 $ لازال ايجابي ويستهدف 0.85 $ ثم 0.88 $ ثم 0.99 $
ولكن في حالة كسر مستويات الدعم الحالي يهبط لمستويات 0.71 $
#السوق_الامريكي
$KLTO provides a strategic update to shareholders highlighting key milestones and pipeline progress.
These achievements strengthen #KLTO's position as it advances toward the large and growing market for #ALS, #AlzheimersDisease, and #ParkinsonsDisease therapies, which is estimated at over $8 billion annually by @GrandViewInc and others.
Read more: https://t.co/cuIy1qd4Qs
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113.7M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.5M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.7M followers
KATY PERRY
@katyperry
89.6M followers
Taylor Swift
@taylorswift13
83.5M followers
Lady Gaga
@ladygaga
75M followers
Virat Kohli
@imvkohli
72.7M followers
Kim Kardashian
@kimkardashian
70.7M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65.7M followers
Bill Gates
@billgates
64.9M followers
Selena Gomez
@selenagomez
62.6M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers